US Stock MarketDetailed Quotes

Allarity Therapeutics (ALLR)

Watchlist
  • 1.340
  • -0.060-4.29%
Close Apr 24 15:59 ET
  • 1.328
  • -0.012-0.91%
Post 20:01 ET
21.20MMarket Cap-1.72P/E (TTM)

Allarity Therapeutics (ALLR) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
14.59%-14.82M
-1.15%-3.24M
37.35%-3.41M
24.96%-5.48M
-91.99%-2.69M
-36.15%-17.35M
-91.75%-3.21M
-1.25%-5.44M
-192.63%-7.3M
56.29%-1.4M
Net income from continuing operations
54.19%-11.23M
54.74%-3.37M
75.79%-2.81M
-42.42%-2.32M
28.91%-2.73M
-105.99%-24.52M
-332.81%-7.45M
-160.63%-11.59M
31.55%-1.63M
-14.65%-3.84M
Operating gains losses
144.13%1.24M
1,169.23%1.25M
--0
99.95%-1K
97.37%-13K
51.95%-2.8M
96.67%-117K
-370.00%-47K
-12.08%-2.14M
-25.00%-495K
Depreciation and amortization
-244.44%-13K
700.00%8K
-980.00%-44K
1,100.00%12K
450.00%11K
-75.68%9K
-88.89%1K
-44.44%5K
-88.89%1K
-80.00%2K
Deferred tax
--0
--0
--0
--0
--0
-559.79%-446K
--0
---432K
--0
---14K
Other non cash items
-31.98%385K
-69.72%119K
117.54%124K
320.00%84K
-39.58%58K
-64.04%566K
67.95%393K
-92.54%57K
-95.91%20K
10.34%96K
Change In working capital
-9,115.87%-5.68M
-133.15%-1.3M
74.14%-816K
4.31%-3.42M
-105.16%-149K
-98.12%63K
12.31%3.91M
-73.79%-3.16M
-419.39%-3.57M
405.60%2.89M
-Change in receivables
-313.33%-96K
-9.75%796K
27.40%-53K
-99.19%-494K
33.14%-345K
273.08%45K
17.91%882K
-508.33%-73K
66.44%-248K
-2,143.48%-516K
-Change in prepaid assets
-685.04%-1.6M
11.80%-314K
-304.19%-439K
-590.91%-864K
-94.14%14K
244.21%274K
7.53%-356K
222.16%215K
-53.32%176K
4,083.33%239K
-Change in payables and accrued expense
-587.79%-3.83M
-150.97%-1.63M
90.18%-327K
40.94%-2.06M
-94.23%177K
-125.02%-557K
38.91%3.19M
-52.43%-3.33M
-333.94%-3.48M
388.84%3.07M
-Change in other current assets
-259.57%-150K
-913.33%-152K
-90.32%3K
71.43%-6K
-94.95%5K
-93.04%94K
-101.83%-15K
-94.42%31K
-200.00%-21K
621.05%99K
-Change in other current liabilities
----
----
----
----
----
--0
--0
--0
--0
--0
-Change in other working capital
----
----
----
----
----
--207K
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
14.59%-14.82M
-1.15%-3.24M
37.35%-3.41M
24.96%-5.48M
-91.99%-2.69M
-36.15%-17.35M
-91.75%-3.21M
-1.25%-5.44M
-192.63%-7.3M
56.29%-1.4M
Investing cash flow
Cash flow from continuing investing activities
97.32%-8K
-298K
Net PPE purchase and sale
97.32%-8K
----
----
----
----
---298K
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
97.32%-8K
----
----
----
----
---298K
----
----
----
----
Financing cash flow
Cash flow from continuing financing activities
-71.06%10.65M
-105.67%-240K
-52.55%2.31M
-109.75%-2.57M
707.46%11.14M
234.62%36.79M
711.30%4.24M
-24.53%4.87M
818.29%26.31M
19.17%1.38M
Net issuance payments of debt
--0
--0
--0
--0
--0
--0
--0
--0
41.69%-1.34M
--1.34M
Net common stock issuance
-71.49%10.65M
-105.67%-240K
-57.46%2.31M
-109.28%-2.57M
27,757.50%11.14M
121.09%37.35M
--4.24M
-67.86%5.43M
--27.65M
--40K
Net preferred stock issuance
--0
--0
----
----
----
89.77%-562K
--0
95.24%-562K
--0
--0
Proceeds from stock option exercised by employees
----
----
----
----
----
--0
--0
--0
----
----
Cash from discontinued financing activities
Financing cash flow
-71.06%10.65M
-105.67%-240K
-52.55%2.31M
-109.75%-2.57M
707.46%11.14M
234.62%36.79M
711.30%4.24M
-24.53%4.87M
818.29%26.31M
19.17%1.38M
Net cash flow
Beginning cash position
11,666.87%19.53M
-8.49%16.9M
-7.45%17.8M
8,779.49%27.7M
11,666.87%19.53M
-91.82%166K
1,219.73%18.46M
4,479.29%19.23M
5.76%312K
-91.82%166K
Current changes in cash
-121.83%-4.18M
-577.43%-3.49M
-91.30%-1.1M
-142.34%-8.05M
44,610.53%8.46M
1,193.83%19.14M
163.57%731K
-153.54%-575K
5,050.41%19.01M
99.07%-19K
Effect of exchange rate changes
-396.44%-667K
278.17%1.28M
199.49%194K
-2,110.71%-1.86M
-273.33%-286K
299.12%225K
508.43%339K
-105.26%-195K
65.57%-84K
-46.60%165K
End cash Position
-24.81%14.69M
-24.81%14.69M
-8.49%16.9M
-7.45%17.8M
8,779.49%27.7M
11,666.87%19.53M
11,666.87%19.53M
1,219.73%18.46M
4,479.29%19.23M
5.76%312K
Free cash flow
15.99%-14.83M
7.22%-3.25M
37.35%-3.41M
24.96%-5.48M
-91.99%-2.69M
-38.49%-17.65M
-109.57%-3.5M
-1.25%-5.44M
-192.63%-7.3M
56.29%-1.4M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 14.59%-14.82M-1.15%-3.24M37.35%-3.41M24.96%-5.48M-91.99%-2.69M-36.15%-17.35M-91.75%-3.21M-1.25%-5.44M-192.63%-7.3M56.29%-1.4M
Net income from continuing operations 54.19%-11.23M54.74%-3.37M75.79%-2.81M-42.42%-2.32M28.91%-2.73M-105.99%-24.52M-332.81%-7.45M-160.63%-11.59M31.55%-1.63M-14.65%-3.84M
Operating gains losses 144.13%1.24M1,169.23%1.25M--099.95%-1K97.37%-13K51.95%-2.8M96.67%-117K-370.00%-47K-12.08%-2.14M-25.00%-495K
Depreciation and amortization -244.44%-13K700.00%8K-980.00%-44K1,100.00%12K450.00%11K-75.68%9K-88.89%1K-44.44%5K-88.89%1K-80.00%2K
Deferred tax --0--0--0--0--0-559.79%-446K--0---432K--0---14K
Other non cash items -31.98%385K-69.72%119K117.54%124K320.00%84K-39.58%58K-64.04%566K67.95%393K-92.54%57K-95.91%20K10.34%96K
Change In working capital -9,115.87%-5.68M-133.15%-1.3M74.14%-816K4.31%-3.42M-105.16%-149K-98.12%63K12.31%3.91M-73.79%-3.16M-419.39%-3.57M405.60%2.89M
-Change in receivables -313.33%-96K-9.75%796K27.40%-53K-99.19%-494K33.14%-345K273.08%45K17.91%882K-508.33%-73K66.44%-248K-2,143.48%-516K
-Change in prepaid assets -685.04%-1.6M11.80%-314K-304.19%-439K-590.91%-864K-94.14%14K244.21%274K7.53%-356K222.16%215K-53.32%176K4,083.33%239K
-Change in payables and accrued expense -587.79%-3.83M-150.97%-1.63M90.18%-327K40.94%-2.06M-94.23%177K-125.02%-557K38.91%3.19M-52.43%-3.33M-333.94%-3.48M388.84%3.07M
-Change in other current assets -259.57%-150K-913.33%-152K-90.32%3K71.43%-6K-94.95%5K-93.04%94K-101.83%-15K-94.42%31K-200.00%-21K621.05%99K
-Change in other current liabilities ----------------------0--0--0--0--0
-Change in other working capital ----------------------207K----------------
Cash from discontinued investing activities
Operating cash flow 14.59%-14.82M-1.15%-3.24M37.35%-3.41M24.96%-5.48M-91.99%-2.69M-36.15%-17.35M-91.75%-3.21M-1.25%-5.44M-192.63%-7.3M56.29%-1.4M
Investing cash flow
Cash flow from continuing investing activities 97.32%-8K-298K
Net PPE purchase and sale 97.32%-8K-------------------298K----------------
Cash from discontinued investing activities
Investing cash flow 97.32%-8K-------------------298K----------------
Financing cash flow
Cash flow from continuing financing activities -71.06%10.65M-105.67%-240K-52.55%2.31M-109.75%-2.57M707.46%11.14M234.62%36.79M711.30%4.24M-24.53%4.87M818.29%26.31M19.17%1.38M
Net issuance payments of debt --0--0--0--0--0--0--0--041.69%-1.34M--1.34M
Net common stock issuance -71.49%10.65M-105.67%-240K-57.46%2.31M-109.28%-2.57M27,757.50%11.14M121.09%37.35M--4.24M-67.86%5.43M--27.65M--40K
Net preferred stock issuance --0--0------------89.77%-562K--095.24%-562K--0--0
Proceeds from stock option exercised by employees ----------------------0--0--0--------
Cash from discontinued financing activities
Financing cash flow -71.06%10.65M-105.67%-240K-52.55%2.31M-109.75%-2.57M707.46%11.14M234.62%36.79M711.30%4.24M-24.53%4.87M818.29%26.31M19.17%1.38M
Net cash flow
Beginning cash position 11,666.87%19.53M-8.49%16.9M-7.45%17.8M8,779.49%27.7M11,666.87%19.53M-91.82%166K1,219.73%18.46M4,479.29%19.23M5.76%312K-91.82%166K
Current changes in cash -121.83%-4.18M-577.43%-3.49M-91.30%-1.1M-142.34%-8.05M44,610.53%8.46M1,193.83%19.14M163.57%731K-153.54%-575K5,050.41%19.01M99.07%-19K
Effect of exchange rate changes -396.44%-667K278.17%1.28M199.49%194K-2,110.71%-1.86M-273.33%-286K299.12%225K508.43%339K-105.26%-195K65.57%-84K-46.60%165K
End cash Position -24.81%14.69M-24.81%14.69M-8.49%16.9M-7.45%17.8M8,779.49%27.7M11,666.87%19.53M11,666.87%19.53M1,219.73%18.46M4,479.29%19.23M5.76%312K
Free cash flow 15.99%-14.83M7.22%-3.25M37.35%-3.41M24.96%-5.48M-91.99%-2.69M-38.49%-17.65M-109.57%-3.5M-1.25%-5.44M-192.63%-7.3M56.29%-1.4M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More